TFF3 and carcinoma: We have shown the majority of residual carcinomas in incomplete pathological response group are expressing high level of TFF3 in pre-neoadjuvant and post neoadjuvant specimens, while the majority of cases with complete pathological response group have no or low expression of TFF3 in pre-neoadjuvant biopsies.